Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2020 FY- Text added to 2021 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
antiretroviral, appeal, argued, ASCO, ASH, asthenia, attrition, belief, benchmarking, billion, bioconjugation, biography, boundary, buying, CCPA, CDE, Center, Chargeback, Chemical, Circuit, cite, clarity, clearance, complicating, composed, conflict, CRL, cut, cytolytic, delete, digit, disability, dismissed, dismissing, double, easier, Eck, effusion, encompassing, erythrodysesthesia, ESMO, explicitly, fatal, fill, flow, futility, GDPR, GMP, guideline, Hengrui, histologically, ID, imaging, Immunotherapy, instructed, intermittent, landscape, latent, listen, lorigerlimab, margetuxumab, mark, midst, mix, move, NDA, NMPA, notification, opt, overexpressed, palmar, Passport, PD, penalty, PK, plantar, pleural, preempted, prejudice, prespecified, proportion, proven, punishable, pursing, reprioritization, resale, resell, Shanghai, shrinkage, SITC, staple, Stephen, stringent, terrorist, Thirteen, thrombocytopenia, unconstitutional, unresectable, unrest, unsaleable, vaccinated, vaccination, vaccine, visibility, whichever, willingly, withdrew, write
Removed:
absent, AG, attribution, Canada, capecitabine, chemotherapeutic, comparative, concluding, controlled, CR, CRi, CrossMAb, de, differentiation, DutaFab, emtansine, eribulin, estimating, extremely, gemcitabine, hematopoietic, improved, incomplete, India, inhibit, Institut, intention, invoiced, jointly, largest, Les, leukemic, leverage, Mexico, network, originally, package, perpetuated, pertuzumab, PFS, pivotal, practical, progression, randomized, reallocation, resist, revaluation, reverse, sequential, Servier, South, stem, Synthon, underwritten, vest, vesting, vinorelbine, white, wide
Valuein 2020 FY filing- Value in 2021 FY filing
Original filings
Filing view